Navigation Links
Overexpression of Notch1 in temporal lobe epilepsy
Date:5/9/2014

Notch1 signaling can induce astrogliosis in glioma. However, it remains unknown whether Notch1 signaling is involved in the pathogenesis of epilepsy. A recent study by Xijin Liu and co-workers from Huazhong University of Science and Technology in China observed overexpression of Notch1 in the brain tissue of temporal lobe epilepsy rats. After Notch1 regulation, it was relatively effective in reducing seizure frequency and reducing brain discharges, thereby resulting in the ease of seizures to a certain extent. Increased presence of Notch 1 and hairy and enhancer of split-1 was also observed in intractable temporal lobe epilepsy patients. Therefore, Notch signaling may play a role in the pathogenesis of epilepsy in temporal lobe epilepsy and its suppression may provide a new treatment to promote remission in epilepsy. These findings were published in the Neural Regeneration Research (Vol. 9, No. 5, 2014).


'/>"/>

Contact: Meng Zhao
eic@nrren.org
86-138-049-98773
Neural Regeneration Research
Source:Eurekalert  

Page: 1

Related medicine news :

1. Overexpression of proteins 14-3-3 related to chemotherapy resistance
2. MRI can screen patients for Alzheimers disease or frontotemporal lobar degeneration
3. Improved detection of frontotemporal degeneration may aid clinical trial efforts
4. Depression common among children with temporal lobe epilepsy
5. Epilepsy Leads to More Brain Abnormalities Over Time
6. Brain surgery for epilepsy underutilized
7. Response to First Treatment May Predict Epilepsys Course
8. Pediatric epilepsy impacts sleep for the child and parents
9. Parents Often Lose Sleep Over Childs Epilepsy, Study Finds
10. Epilepsy drugs increase risk of fractures and falls
11. Study finds new gene mutations that lead to enlarged brain size, cancer, autism, epilepsy
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Overexpression of Notch1 in temporal lobe epilepsy
(Date:2/12/2016)... ... ... Fisher House Foundation Chairman and CEO Kenneth Fisher joined Governor Brian Sandoval, ... Scott Bensing, and Peggy Kearns Director, VA Southern Nevada Healthcare System yesterday to dedicate ... be the first Fisher House in Nevada, and will provide free lodging for families ...
(Date:2/12/2016)... ... 2016 , ... Young Asset Protection, a full service insurance ... latest charity campaign in their community enrichment program. Art Expression utilizes after-school programs ... are currently being accepted at: http://artexpressioninc.org/ . , Art Expression is a ...
(Date:2/12/2016)... ... 12, 2016 , ... Mediaplanet today announces the launch of ... of “Revolutionizing Cancer Care” is distributed within the February 12 issue of USA ... circulation of approximately 250,000 copies and an estimated readership of 750,000 readers. The ...
(Date:2/12/2016)... ... 12, 2016 , ... A lot has been reported about the fitness routines ... to health and wellness resources most Americans could ever dream of having at their ... schedule as frenetic as the U.S. President. , In honor of President’s Day ...
(Date:2/12/2016)... (PRWEB) , ... February 12, 2016 , ... Basketball is ... and integral part of the Peety PoppersTM series, sign language translation is featured in ... of health and wellness in Peety PoppersTM lessons has a sign language translator to ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... , Feb. 12, 2016 On Thursday, Feb. ... Surgery at St. David,s North Austin Medical Center successfully ... ® Xi ® Surgical System with Trumpf ... Thiru Lakshman , M.D., colorectal surgeon at ... proctocolectomy utilizing Integrated Table Motion technology, which seamlessly combines ...
(Date:2/12/2016)... , Feb. 12, 2016  Aralez Pharmaceuticals Inc. (Nasdaq: ... announced the Company will ring the Nasdaq Closing Bell ... New York at 4:00 p.m. ET on ... Aralez. Adrian Adams , will perform ... 3:50 to 4:00 p.m. ET.  A live webcast will ...
(Date:2/12/2016)... 2016  Apellis Pharmaceuticals, Inc., today announced ... Series D preferred stock financing, co-led by ... Group and venBio Global Strategic Fund, joining ... Investment, and Epidarex Capital. The proceeds of the ... clinical trials in the Company,s ongoing complement ...
Breaking Medicine Technology: